BE809169A - Derives de la famille des delta 2-prostaglandines - Google Patents

Derives de la famille des delta 2-prostaglandines

Info

Publication number
BE809169A
BE809169A BE139330A BE139330A BE809169A BE 809169 A BE809169 A BE 809169A BE 139330 A BE139330 A BE 139330A BE 139330 A BE139330 A BE 139330A BE 809169 A BE809169 A BE 809169A
Authority
BE
Belgium
Prior art keywords
prostaglandines
delta
family
derivatives
prostaglandines family
Prior art date
Application number
BE139330A
Other languages
English (en)
French (fr)
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP242773A external-priority patent/JPS5336458B2/ja
Priority claimed from JP12279673A external-priority patent/JPS5653545B2/ja
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of BE809169A publication Critical patent/BE809169A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE139330A 1972-12-29 1973-12-27 Derives de la famille des delta 2-prostaglandines BE809169A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP242773A JPS5336458B2 (zh) 1972-12-29 1972-12-29
JP12279673A JPS5653545B2 (zh) 1973-11-02 1973-11-02

Publications (1)

Publication Number Publication Date
BE809169A true BE809169A (fr) 1974-06-27

Family

ID=26335786

Family Applications (1)

Application Number Title Priority Date Filing Date
BE139330A BE809169A (fr) 1972-12-29 1973-12-27 Derives de la famille des delta 2-prostaglandines

Country Status (11)

Country Link
US (1) US3931296A (zh)
AU (1) AU476655B2 (zh)
BE (1) BE809169A (zh)
CA (1) CA1026329A (zh)
CH (1) CH605727A5 (zh)
DE (1) DE2365035C2 (zh)
FR (1) FR2212146B1 (zh)
GB (1) GB1416410A (zh)
HK (1) HK14279A (zh)
NL (1) NL7317804A (zh)
SE (1) SE399423B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4052512A (en) * 1976-01-05 1977-10-04 Ono Pharmaceutical Co., Ltd. Prostaglandin analogues
NL7700010A (nl) * 1972-12-29 1977-07-07 Ono Pharmaceutical Co Prostaglandinederivaten.
GB1482010A (en) * 1974-10-28 1977-08-03 Ono Pharmaceutical Co Prostaglandin analogues
GB1520942A (en) * 1976-02-10 1978-08-09 Ono Pharmaceutical Co Postaglandin analogues
US4165437A (en) * 1976-03-12 1979-08-21 Ono Pharmaceutical Company, Ltd. Δ3 -Prostaglandin analogs
GB1588196A (en) * 1977-06-14 1981-04-15 Ono Pharmaceutical Co Prostaglandin analogues
US4176282A (en) * 1978-03-21 1979-11-27 The Upjohn Company 2-Decarboxy-2-alkylcarbonyl-3,7-inter-m-phenylene-3-oxa-4,5,6-trinor-PGF1 compounds
US4123463A (en) * 1978-03-21 1978-10-31 The Upjohn Company 2-Decarboxy-2-alkylketone prostaglandins
DE2834249A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-11-desoxy-pgf tief 2 bzw. pge tief 2 -reihe
IT1149877B (it) * 1979-01-25 1986-12-10 Ono Pharmaceutical Co Prodotti intermedi per analoghi della prostaglandina
JPS6036422B2 (ja) * 1979-01-29 1985-08-20 小野薬品工業株式会社 プロスタグランジン類似化合物及びその製造方法
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
US5166369A (en) * 1981-05-21 1992-11-24 American Cyanamid Company Precursors and synthesis of D1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates
US4360688A (en) * 1981-05-21 1982-11-23 American Cyanamid Company Precursors and synthesis of d1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates
DE3315356A1 (de) * 1982-04-30 1983-11-17 Ono Pharmaceutical Co. Ltd., Osaka Verwendung von prostaglandinanalogen
JPS595154A (ja) * 1982-06-30 1984-01-12 Ono Pharmaceut Co Ltd プロスタグランジンｄ類似化合物
CN105985370B (zh) * 2015-02-11 2019-06-18 常州博海威医药科技股份有限公司 制备利马前列腺素的关键中间体及其应用
CN105985371B (zh) * 2015-02-11 2019-06-18 常州博海威医药科技股份有限公司 制备利马前列腺素的关键中间体及其应用
DK3456710T3 (da) 2016-05-09 2021-09-13 Agc Inc Nyt prostaglandinderivat
EP3705472B1 (en) 2017-10-31 2023-06-21 AGC Inc. Method for producing prostaglandin derivative

Also Published As

Publication number Publication date
US3931296A (en) 1976-01-06
AU476655B2 (en) 1976-09-30
DE2365035A1 (de) 1974-07-04
GB1416410A (en) 1975-12-03
HK14279A (en) 1979-03-30
SE399423B (sv) 1978-02-13
FR2212146B1 (zh) 1978-07-28
DE2365035C2 (de) 1986-04-24
FR2212146A1 (zh) 1974-07-26
NL7317804A (zh) 1974-07-02
CH605727A5 (zh) 1978-10-13
AU6407173A (en) 1975-07-03
CA1026329A (en) 1978-02-14

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
BE804913A (fr) Derives tetracycliniques
BE809169A (fr) Derives de la famille des delta 2-prostaglandines
SE390819B (sv) Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
BE808035A (fr) Derives de gamma-glutamyl-p-nitranilide
BE780675A (fr) Derives de 3-nitropyrazole
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
AR214383A1 (es) Derivados de dialquilfosfanatos
BE817658A (fr) Derives de camphre
AR201288A1 (es) Derivados de alfa-cianmetansulfonamidobenceno
BE822780A (fr) Derives de cepheme
FI55033B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva pyrazin-4-oxidderivat
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
BE778052A (fr) Derives substitues de la
BE796540A (fr) Derives cephalosporins
SE7602150L (sv) Mellanprodukter for framstellning av 4a-aryl-trans-dekahydroisokinolin
BE805839A (fr) Derives de la classe des carbamoyl sulfoxydes
SE403112B (sv) Analogiforfarande for framstellning av skopolaminderivat
BE823023A (fr) Derives de la quinoleine
BE789320A (fr) Derives de dibenzoxirenazepine

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ONO PHARMACEUTICAL CO. LTD

Effective date: 19931227